Lee, J. L., Shin, S. J., Park, I., Bae, W. K., Yoon, S., Kim, I., Chon, H. J., Shim, B. Y., Kim, J. Y., Kim, J. H., Park, J., Kim, I. H., Kim, M., Park, K., Lee, H. J. (2025). Cabozantinib as subsequent therapy to an immune checkpoint-based therapy in renal cell carcinoma, phase 2 interventional study (AT ASIA, KCSG GU21-02).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.547